Safety of Low-Dose Oral Treprostinil in PH-HFpEF Supports Use in Patients with PAH with Cardiovascular Comorbidities

Authors
Category Primary study
ConferenceJournal of Heart and Lung Transplantation
Year 2025
This article has no abstract
Epistemonikos ID: d2c7b112156ff857c4628d04d7d82cb959935751
First added on: Apr 29, 2026